Advanced Visualization Market: By Product & Service (Hardware, Software, Services), By Type of Solution (Enterprise, Standalone), By Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Nuclear Medicine, Other), By Clinical Application (Oncology, Orthopedics, Cardiovascular, Neurology, Others) and Geography  

The Advanced Visualization market is estimated to be valued at USD 3,214.6 Million in 2021 and is poised to grow at a significant CAGR of 11.6% over 2022-2028. Advanced visualization systems are medical devices outfitted with advanced software that efficiently displays the various aspects of a living cell. These systems reduce the time it takes clinicians to report results to patients. These systems are widely used in pathological laboratories for various clinical applications. Based on the clinical application, the global advanced visualization market has been segmented into Oncology, Orthopedics, Cardiovascular, Neurology, and Others. The oncology segment is anticipated to grow at a significant CAGR over the forecast years, owing to increased technological advancements in advanced visualization technology and software, rising prevalence of chronic diseases, increasing geriatric population, and the need for efficiency. Early diagnosis and rising awareness of the benefits of advanced visualization tools in disease diagnosis drive the global advanced visualization market. The increasing prevalence of chronic diseases, rising geriatric population, need for efficient and early diagnosis, and growing awareness of the benefits offered by advanced visualization tools in disease diagnosis are the factors driving the global advanced visualization market.

Key Developments:

In October 2020, GE Healthcare launched that its Ultra Edition package for Vivid1 cardiovascular ultrasound systems has received 510k clearance from the US FDA. The system includes new Artificial Intelligence (AI) that enables clinicians to acquire faster, more repeatable exams consistently.